Dr. Srikanth Damaraju, MD

Dr. Damaraju practices at Coastal Cardiology Association in Corpus Christi, Texas.

Dr. Damaraju's NPI, 1790785442, was assigned on July 22, 2005. Dr. Damaraju graduated from Jawaharlal Institute of Postgraduate Medical Education and Research in 1991. Dr. Damaraju holds Texas license K4034.

Dr. Damaraju's primary practice is Coastal Cardiology Association, at 613 Elizabeth St, Corpus Christi, TX 78404 in Nueces County. The practice phone is (361) 887-2900.

Dr. Damaraju's primary practice is Coastal Cardiology Association in Corpus Christi, Texas. Dr. Damaraju is also affiliated with CHRISTUS Spohn Hospital Corpus Christi - Shoreline. The medical group on file is Coastal Cardiology PLLC. Dmand AI also links Dr. Damaraju to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Damaraju practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Damaraju's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Damaraju is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Damaraju's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Damaraju treats.

CMS data shows 4,833 Medicare services from Dr. Damaraju across 41 procedure codes in 2024, for 1,065 Medicare patients. Medicare paid $307,157 for them.

CMS counts 1,065 Medicare patients who saw Dr. Damaraju in 2024. The largest group is 65 to 74, with 431 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Damaraju's median patient age at 70, with 43% women.

In 2024, Dr. Damaraju wrote 8,560 Medicare Part D claims for 1,213 patients. 83% of them were for generic drugs. CMS names the drug for 8,285 of them, across 72 drugs with 11 or more claims each, at $1,786,558 in total drug cost. In 2023, CMS named 7,465 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Damaraju for performance year 2024, reported individually. Dr. Damaraju accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of coronary angioplasty and stenting by Dr. Damaraju, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Damaraju, published from 2020 to 2021. The most frequent topics are COVID-19. Dr. Damaraju has published most often in Cardiology. Dr. Damaraju's most frequent co-authors are Efstratios Koutroumpakis, MD and Travis Paul Taylor, MD.

Dmand AI links Dr. Damaraju to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 972 general payments to Dr. Damaraju from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Medtronic, Inc. paid the most, $6,877.

Dr. Damaraju graduated from Jawaharlal Institute of Postgraduate Medical Education and Research in 1991.

Dr. Damaraju is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.